From 2008 to 2016, Cancer Council NSW funded the B Positive program, to increase awareness of the link between chronic hepatitis B infection and liver cancer. The program worked with affected communities and their General Practitioners in Sydney regions with a large caseload of chronic hepatitis B (CHB) infection. The program’s objectives were to increase hepatitis B testing in high risk population groups and to support local General Practitioners deliver guideline-based hepatitis B care for their patients. Over 1,600 people were enrolled in B Positive study (or program) and hepatitis B treatment rates reached levels recommended by hepatitis B treatment guidelines, which were 3 times higher than the national average.
While the B Positive program is now closed, enrolled participants will continue to receive high quality care from our General Practitioner collaborators.
This website offers access to the B Positive information and education resources about hepatitis B and liver cancer, answering many of the commonly asked questions of people affected by chronic hepatitis B or liver cancer.